Yoh Zen

2001–2025 年に発表

151
論文数
29,256
被引用数
88
h 指数
142
i10 指数

被引用数

Yoh Zen の年別被引用数1993 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 9 件2003 年: 被引用 7 件2004 年: 被引用 24 件2005 年: 被引用 31 件2006 年: 被引用 51 件2007 年: 被引用 76 件2008 年: 被引用 106 件2009 年: 被引用 178 件2010 年: 被引用 251 件2011 年: 被引用 220 件2012 年: 被引用 248 件2013 年: 被引用 223 件2014 年: 被引用 276 件2015 年: 被引用 258 件2016 年: 被引用 221 件2017 年: 被引用 207 件2018 年: 被引用 178 件2019 年: 被引用 793 件2020 年: 被引用 836 件2021 年: 被引用 648 件2022 年: 被引用 457 件2023 年: 被引用 361 件2024 年: 被引用 649 件2025 年: 被引用 269 件2026 年: 被引用 4 件1994〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,226 件、この内訳の 19.1%日本: 引用元論文 849 件、この内訳の 13.3%中国: 引用元論文 746 件、この内訳の 11.6%イタリア: 引用元論文 414 件、この内訳の 6.5%イギリス: 引用元論文 394 件、この内訳の 6.1%ドイツ: 引用元論文 307 件、この内訳の 4.8%フランス: 引用元論文 252 件、この内訳の 3.9%韓国: 引用元論文 190 件、この内訳の 3%カナダ: 引用元論文 174 件、この内訳の 2.7%スペイン: 引用元論文 162 件、この内訳の 2.5%オランダ: 引用元論文 151 件、この内訳の 2.4%オーストラリア: 引用元論文 107 件、この内訳の 1.7%
0%19.1%その他 22.4%

分野

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology10.5%
  • Immunology and Microbiology2.6%
  • Engineering0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.4%
  • その他1.3%

トピック

  • IgG4-Related and Inflammatory Diseases7.9%
  • Liver Disease Diagnosis and Treatment6.5%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.1%
  • Liver Diseases and Immunity4%
  • Neuroendocrine Tumor Research Advances3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis2.9%
  • その他70.7%

共著者

全論文

検索で開く
  1. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

    著者: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 739

  2. IgG4-Related Disease

    著者: , , - New England Journal of Medicine 2012 被引用: 2,597

  3. Consensus statement on the pathology of IgG4-related disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ji Kon Ryu, Takako Saeki, Dushyant V. Sahani, Thomas C. Smyrk, James R. Stone, Masayuki Takahira, George Webster, Motohisa Yamamoto, Giuseppe Zamboni, Hisanori Umehara, John H. Stone - Modern Pathology 2012 被引用: 2,577

  4. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 被引用: 658

  5. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Licata, M. Isabel Lucena, Giorgina Mieli‐Vergani, Diego Vergani, Einar S. Björnsson - Journal of Hepatology 2023 被引用: 150

  6. IgG4-related disease

    著者: , , , - The Lancet 2014 被引用: 1,200

  7. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magda El-Monayeri, Paulo Fontes, Emma E. Furth, Annette S.H. Gouw, Sara Hafezi‐Bakhtiari, John Hart, Eva Honsová, W. Ismail, Takeshi Itoh, N. Jhala, Urmila Khettry, Göran B. Klintmalm, Stuart J. Knechtle, T Koshiba, Tomasz Kozłowski, Charles Lassman, Jan Lerut, Josh Levitsky, Lisa Licini, Rosa Liotta, George Mazariegos, Marta I. Minervini, Joseph Misdraji, Thalachallour Mohanakumar, Johan Mölne, Imad Nasser, James Neuberger, Marsha O'Neil, Orit Pappo, L. Petrovič, Phillip Ruiz, Özgül Sağol, A. Sanchez Fueyo, Eizaburo Sasatomi, Abraham Shaked, M. Shiller, Takahiro Shimizu, B. Sis, Aurelio Sonzogni, Heather L. Stevenson, Swan N. Thung, Giuseppe Tisone, Athanassios C. Tsamandas, Annika Wernerson, Ting-Jung Wu, Adriana Zeevi, Yoh Zen - American Journal of Transplantation 2016 被引用: 627

  8. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 97

  9. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Per Sandström, Frederique L. Vissers, Ulrich F. Wellner, Alessandro Zerbi, Marcel G. W. Dijkgraaf, Marc G. Besselink, Mohammad Abu Hilal, Adnan Alseidi, Constanza Aquilano, Johanna Arola, Denise Bianchi, Rachel M. Brown, Daniela Campani, Joanne Chin‐Aleong, Jérôme Cros, Lyubomira Dimitrova, Claudio Doglioni, Safi Dokmak, Russell Dorer, Michael Doukas, J Fabré, Giovanni Ferrari, В. Н. Гриневич, Stefano Gobbo, Thilo Hackert, Marius van den Heuvel, Clement Huijsentruijt, Mar Iglesias, Casper Jansen, Igor Khatkov, David A. Kooby, Marco Schiavo Lena, Claudio Luchini, Krishna Menon, Patrick Michenet, Q. Molenaar, Anna Nedkova, Andrea Pietrabissa, Mihaela Raicu, Rushda Rajak, Branislava Ranković, Aniko Rendek, Benjamin Rivière, António Sá Cunha, Olivier Saint Marc, Patricia Sánchez‐Velázquez, Donatella Santini, Aldo Scarpa, Mylène Sebagh, Donald L. Sears, Mihir M. Shah, Zahir Soonawalla, Paola Spaggiari, Lars Tharun, Tore Tholfsen, Aleš Tomažič, Alessandro Vanoli, Caroline S. Verbeke, Joanne Verheij, Moritz von Winterfeld, Roeland F. de Wilde, Vincent Yip, Yoh Zen - The Lancet Regional Health - Europe 2023 被引用: 123

  10. cHCC‐CCA

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew M. Yeh, Yoh Zen, Jessica Zucman‐Rossi, Neil D. Theise - Hepatology 2018 被引用: 331

  11. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury

    著者: , - Modern Pathology 2018 被引用: 288

  12. Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome

    著者: , , , , , , , - Hepatology 2021 被引用: 87

  13. GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Nature 2022 被引用: 83

  14. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2012 被引用: 582

  15. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , - Hepatology 2012 被引用: 283

  16. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas

    著者: , , , , , , , , - Modern Pathology 2017 被引用: 133

  17. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Pathology International 2010 被引用: 219

  18. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , - Gut 2023 被引用: 74

  19. Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort

    著者: , , , , , , , - Liver International 2022 被引用: 42

  20. Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes

    著者: , , , , - Histopathology 2019 被引用: 84

  21. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities

    著者: - Human Pathology 2022 被引用: 54

  22. Fibrotic phenotype of IgG4-related disease

    著者: , , , , , , - The Lancet Rheumatology 2024 被引用: 49

  23. Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis

    著者: , , , , , , , , , , , , , , , , , , - Hepatology 2021 被引用: 46

  24. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis

    著者: , , , , , , , , , , , , - Liver International 2014 被引用: 145